23 May 2025
23 May 2025
Dubbed a "big, beautiful bill" by the White House, observers warn that the legislation will profoundly impact Medicaid and Medicare programmes.
ID Solutions will produce and supply dPCR assays for use in non-clinical research on Qiagen's QIAcuity platforms.
The IKON Allograft Surgical Matrix aids in incision management and sternal closures.
Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months.
Featuring an 88-element phased linear array, the catheter claims to deliver detailed visualisation.
The randomised, controlled trial assessed the system's safety and efficacy.
Biolife's haemostatic devices are manufactured under the StatSeal and WoundSeal brand names.
The trial will be carried out at various orthopaedic centres in the US and Europe, focusing on the device’s safety.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
